| 英文名称 | Asperosaponin Ⅵ |
|---|---|
| 中文名称 | 川续断皂苷VI/木通皂苷D/木通皂甙D/川续断皂苷Ⅵ |
| CAS号 | 39524-08-8 |
| 分子式 | C47H76O18 |
| 分子量 | 929.10 |
| 外观 | 白色粉末 |
| 熔点 | 234-235 °C |
| 沸点 | 990.2±65.0 °C | Condition: Press: 760 Torr |
| 酸度系数pKa | 12.50±0.70 | Condition: Most Acidic Temp: 25 °C |
| 英文名称 | Asperosaponin Ⅵ |
|---|---|
| 中文名称 | 川续断皂苷VI/木通皂苷D/木通皂甙D/川续断皂苷Ⅵ |
| CAS号 | 39524-08-8 |
| 分子式 | C47H76O18 |
| 分子量 | 929.10 |
| 外观 | 白色粉末 |
| 熔点 | 234-235 °C |
| 沸点 | 990.2±65.0 °C | Condition: Press: 760 Torr |
| 酸度系数pKa | 12.50±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000133
中文名称：川续断皂苷VI
中文别名：木通皂苷D；木通皂甙D；川续断皂苷Ⅵ
英文名称：Asperosaponin Ⅵ
英文别名：3-O-α-L-Arabinopyranosylhederagenin 28-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranoside;Akebia saponin D;Asperosaponin VI;Hederagenin 3-O-α-L-arabinopyranosyl-28-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside;Leiyemudanoside A;Tauroside St-G0-1;
分子式：C47H76O18
分子量：929.10
CAS号：39524-08-8
纯度：HPLC≥98%
熔点：234-235 °C
沸点：990.2±65.0 °C | Condition: Press: 760 Torr
密度：1.43±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度数：12.50±0.70 | Condition: Most Acidic Temp: 25 °C
储存条件：-20℃，干燥、避光、密封
规格：5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装
供应单位：四川省维克奇生物科技有限公司
供应电话：028-81700200/4008005713
四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体，主打中药对照品/标准品/天然植物有效单体，化学合成，抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等，敬请关注！ 新批次有现货，欢迎咨询。
| Comparative pharmacokinetic analysis of extracts of crude and wine-processed Dipsacus asper in rats by a sensitive ultra performance liquid chromatography–tandem mass spectrometry approach | ||
| 来源：SCI：JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 作者：Yi Tao | 备注：影响因子：2.687 |
| 引用描述 | ||
4-Caffeoylquinic acid(4-CQA), chlorogenic acid(3-CQA), 3,5-dicaffeoylquinic acid(3,5-diCQA), loganic acid, loganin, sweroside, dipsacoside B and asperosaponin VI were purchased from Sichuan Weikeqi Biotechnology Co. Chloramphenicol and glycyrrhetinic acid were purchased from Shanghai Yuanye Biological Technology Co. | ||
| Integrating UHPLC–MS/MS quantification and DAS analysis to investigate the effects of wine-processing on the tissue distributions of bioactive constituents of herbs in rats: Exemplarily shown for Dipsacus asper | ||
| 来源：SCI：JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 作者：Yi Tao | 备注：影响因子：2.603 |
| 引用描述 | ||
authenticated by Prof.Cai Baochang, Director of Jiangsu Key Laboratory of Chinese Medicine Processing, Nanjing University of Chinese Medicine. Standard substances were purchased from Sichuan Weikeqi Biotechnology Co located in Chengdu City, Sichuan Province, including 4-caffeoylquinic acid (4-CQA), chlorogenic acid (3-CQA), 3,5-dicaffeoylquinic acid (3,5-diCQA), loganic acid, loganin, and asperosaponin VI. | ||
| UHPLC–MS/MS quantification combined with chemometrics for the comparative analysis of different batches of raw and wine-processed Dipsacus asper | ||
| 来源：SCI：JOURNAL OF SEPARATION SCIENCE | 作者：Yi Tao | 备注：影响因子：2.557 |
| 引用描述 | ||
Standard compounds, including 4-caffeoylquinic acid (4-CQA), chlorogenic acid (3-CQA), 3,5-dicaffeoylquinic acid (3,5-diCQA), loganic acid, loganin, sweroside, dipsacoside B, and asperosaponin VI were purchased from Sichuan Weikeqi Biotechnology. Chloramphenicol and glycyrrhetinic acid were obtained from Shanghai Yuanye Biological Technology. The purity of each standard substance was more than 98%. HPLC-grade acetonitrile was obtained from Merck. | ||
| Simultaneous Determination of Ten Bioactive Components in Raw and Processed Radix Dipsaci by UPLC-Q-TOF-MS | ||
| 来源：SCI：JOURNAL OF CHROMATOGRAPHIC SCIENCE | 作者：Tao Yi | 备注：影响因子：1.216 |
| 引用描述 | ||
Standard substances, including 4-caffeoylquinic acid (4-CQA), loganic acid, 3,4-dicaffeoylquinic acid (3,4-diCQA), 3,5-dicaffeoylquinic acid (3,5-diCQA), loganin, sweroside and asperosaponin VI were purchased from Sichuan Weikeqi Biotechnology Co. Dipsacussaponin B, asperosaponin V and dipsacoside A were obtained from Nanjing Shizhou Biological Technology Co. The purity of each standard substance was >98%. Their chemical structures are shown in Supplementary Figure S1. | ||
